Jiangsu Historical Income Statement

688399 Stock   70.20  0.17  0.24%   
Historical analysis of Jiangsu Bioperfectus income statement accounts such as Interest Expense of 7.3 M, Selling General Administrative of 275.6 M or Total Revenue of 383 M can show how well Jiangsu Bioperfectus Technologies performed in making a profits. Evaluating Jiangsu Bioperfectus income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Jiangsu Bioperfectus's future profits or losses.
 
Covid
Financial Statement Analysis is much more than just reviewing and examining Jiangsu Bioperfectus latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Jiangsu Bioperfectus is a good buy for the upcoming year.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Jiangsu Bioperfectus Technologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

About Jiangsu Income Statement Analysis

Jiangsu Bioperfectus Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Jiangsu Bioperfectus shareholders. The income statement also shows Jiangsu investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Jiangsu Bioperfectus Income Statement Chart

At present, Jiangsu Bioperfectus' Net Interest Income is projected to increase significantly based on the last few years of reporting. The current year's Interest Expense is expected to grow to about 7.3 M, whereas Tax Provision is projected to grow to (1.8 M).

Total Revenue

Total revenue comprises all receipts Jiangsu Bioperfectus generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Gross Profit

Gross profit is a required income statement account that reflects total revenue of Jiangsu Bioperfectus Technologies minus its cost of goods sold. It is profit before Jiangsu Bioperfectus operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.
Most accounts from Jiangsu Bioperfectus' income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Jiangsu Bioperfectus current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Jiangsu Bioperfectus Technologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
At present, Jiangsu Bioperfectus' Net Interest Income is projected to increase significantly based on the last few years of reporting. The current year's Interest Expense is expected to grow to about 7.3 M, whereas Tax Provision is projected to grow to (1.8 M).
 2021 2022 2023 2024 (projected)
Gross Profit2.0B3.4B257.7M244.8M
Total Revenue2.8B5.5B403.2M383.0M

Jiangsu Bioperfectus income statement Correlations

0.320.880.980.990.990.980.430.760.950.920.990.980.330.410.460.640.46
0.320.70.410.40.250.130.990.820.430.60.160.131.00.980.980.860.98
0.880.70.890.910.830.780.780.930.860.930.790.780.710.760.80.840.81
0.980.410.891.00.980.950.520.820.990.970.950.950.420.50.540.730.54
0.990.40.911.00.990.960.50.810.970.960.970.960.410.480.530.70.53
0.990.250.830.980.990.990.360.720.960.910.990.990.260.350.390.60.39
0.980.130.780.950.960.990.240.620.910.841.01.00.140.220.270.490.28
0.430.990.780.520.50.360.240.880.530.690.270.240.991.01.00.891.0
0.760.820.930.820.810.720.620.880.820.90.640.620.830.870.880.970.88
0.950.430.860.990.970.960.910.530.820.980.920.910.440.510.540.760.54
0.920.60.930.970.960.910.840.690.90.980.860.840.610.680.70.840.7
0.990.160.790.950.970.991.00.270.640.920.861.00.170.250.30.510.3
0.980.130.780.950.960.991.00.240.620.910.841.00.140.220.270.490.28
0.331.00.710.420.410.260.140.990.830.440.610.170.140.980.980.860.98
0.410.980.760.50.480.350.221.00.870.510.680.250.220.980.990.890.99
0.460.980.80.540.530.390.271.00.880.540.70.30.270.980.990.891.0
0.640.860.840.730.70.60.490.890.970.760.840.510.490.860.890.890.89
0.460.980.810.540.530.390.281.00.880.540.70.30.280.980.991.00.89
Click cells to compare fundamentals

Jiangsu Bioperfectus Account Relationship Matchups

Jiangsu Bioperfectus income statement Accounts

201920202021202220232024 (projected)
Tax Provision10.9M141.4M198.6M310.8M(1.9M)(1.8M)
Net Interest Income3.9M7.5M22.6M33.4M48.9M51.3M
Interest Expense3.9M83.1K4.0M5.3M6.9M7.3M
Selling General Administrative96.6M340.9M462.8M547.3M291.8M275.6M
Total Revenue288.8M1.7B2.8B5.5B403.2M383.0M
Gross Profit236.1M1.3B2.0B3.4B257.7M244.8M
Operating Income91.0M939.1M1.4B2.5B(214.5M)(203.8M)
Net Income From Continuing Ops83.8M819.6M1.2B1.8B(373.8M)(355.1M)
Ebit83.4M911.0M1.3B2.5B2.8B3.0B
Research Development38.6M72.1M106.6M185.8M135.5M82.6M
Cost Of Revenue52.7M389.9M876.3M2.2B145.5M138.2M
Total Operating Expenses197.8M800.5M1.5B3.1B617.7M907.9M
Income Before Tax94.7M961.0M1.4B2.1B(375.7M)(356.9M)
Net Income83.8M819.6M1.2B1.8B(373.8M)(355.1M)
Interest Income4.0M7.8M26.8M39.2M56.0M58.8M
Other Operating Expenses1.5M5.0M5.3M11.0M12.6M13.3M
Ebitda108.1M983.2M1.4B2.2B2.6B2.7B
Reconciled Depreciation17.4M22.1M41.3M94.0M78.9M43.6M
Net Income Applicable To Common Shares83.8M819.6M1.2B1.8B2.1B2.2B
Income Tax Expense10.9M141.4M198.6M310.8M357.4M375.3M

Currently Active Assets on Macroaxis

Other Information on Investing in Jiangsu Stock

Jiangsu Bioperfectus Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Jiangsu Bioperfectus shareholders. The income statement also shows Jiangsu investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).